Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...

Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over ...

For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online ...

They mimic a natural hormone found in the body called glucagon-like peptide-1 (GLP-1). The medication, like your body’s natural GLP-1, plays a big part in managing blood sugar and appetite.

Semaglutide works by mimicking a protein in your body called glucagon-like peptide 1, a.k.a. GLP-1—the same GLP-1 that keeps coming up all over the place lately, says Kunal Shah, MD, an ...

Fatty liver disease is a growing global health concern. Proglucagon-derived peptides (PGDPs), including glucagon, GLP-1, and GLP-2, are known to regulate lipid metabolism in the liver. However ...

The event will feature: What are GLP-1s (glucagon-like peptides) and how they work Who are candidates for these medications Maximizing results and minimizing potential side effects The importance ...

Dr. Patricia Brubaker has spent decades researching and speaking on studies relating to the development of the intestinal hormone glucagon-like peptide-1 (GLP-1) for the treatment of patients with ...

Another factor is the increased use of glucagon-like peptide-1 (GLP-1) drugs to treat obesity and Type 2 diabetes. The drugs, sold under brand names such as Wegovy and Ozempic, have become popular ...

Concerns over the glucagon-like peptide-1 (GLP-1) drugs currently leading the treatment of obesity and type 2 diabetes follow clinical studies that suggested patients lost muscle at far faster ...

Just like amino acids, peptides occur naturally in the body, but you can also get them from external things, like food and ...